Elena H. Lapiscina-Martinez

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 83 publications

Paediatric medicines development for Duchenne muscular dystrophy: An EU regulatory perspective.

Paediatric medicines development for Duchenne muscular dystrophy: An EU regulatory perspective.

Journal: Journal of neuromuscular diseases

Published: November 18, 2025

Retinal Changes After Acute and Late Optic Neuritis in Aquaporin-4 Antibody Seropositive NMOSD.

Retinal Changes After Acute and Late Optic Neuritis in Aquaporin-4 Antibody Seropositive NMOSD.

Journal: Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society

Published: January 14, 2025

Comorbidities Are Associated With Unfavorable Outcome in Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorders and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: Exploratory Study From the CROCTINO Cohort.

Comorbidities Are Associated With Unfavorable Outcome in Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorders and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: Exploratory Study From the CROCTINO Cohort.

Journal: European journal of neurology

Published: January 12, 2025

Retinal Damage and Visual Network Reconfiguration Defines Visual Function Recovery in Optic Neuritis.

Retinal Damage and Visual Network Reconfiguration Defines Visual Function Recovery in Optic Neuritis.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: August 30, 2024

Retinal Changes in Double-Antibody Seronegative Neuromyelitis Optica Spectrum Disorders.

Retinal Changes in Double-Antibody Seronegative Neuromyelitis Optica Spectrum Disorders.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: June 28, 2024

Tofersen for SOD-1-associated amyotrophic lateral sclerosis.

Tofersen for SOD-1-associated amyotrophic lateral sclerosis.

Journal: The Lancet. Neurology

Published: May 22, 2024

Enhancing diversity of clinical trial populations in multiple sclerosis.

Enhancing diversity of clinical trial populations in multiple sclerosis.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: August 09, 2023

Predictive value of retinal atrophy for cognitive decline across disease duration in multiple sclerosis.

Predictive value of retinal atrophy for cognitive decline across disease duration in multiple sclerosis.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: July 28, 2023

Predicting disease severity in multiple sclerosis using multimodal data and machine learning.

Predicting disease severity in multiple sclerosis using multimodal data and machine learning.

Journal: Journal of neurology

Published: June 24, 2023

Multiscale networks in multiple sclerosis.

Multiscale networks in multiple sclerosis.

Journal: PLoS computational biology

Published: February 25, 2023

Treatment of Patients with Multiple Sclerosis Transitioning Between Relapsing and Progressive Disease.

Treatment of Patients with Multiple Sclerosis Transitioning Between Relapsing and Progressive Disease.

Journal: CNS drugs

Published: November 16, 2022

Diagnostic value of intereye difference metrics for optic neuritis in aquaporin-4 antibody seropositive neuromyelitis optica spectrum disorders.

Diagnostic value of intereye difference metrics for optic neuritis in aquaporin-4 antibody seropositive neuromyelitis optica spectrum disorders.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: October 26, 2022

Showing 1-12 of 83

Last Updated: 09/26/2026